Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome

Fertility and Sterility

Volumn 93, Issue 3, 2010, Pages 869-873

  Chan, Te Fu ^a,b   Tsai, Yung Chieh ^c,d   Chiu, Pu Rong ^a   Chen, Yi Ling ^b   Lee, Chien Hung ^a   Tsai, Eing Mei ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

polycystic ovary syndrome; RBP4; triglycerides

Indexed keywords

ESTROGEN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; RETINOL BINDING PROTEIN 4; THYROTROPIN; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST HIP RATIO;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LOGISTIC MODELS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; POLYCYSTIC OVARY SYNDROME; RETINOL-BINDING PROTEINS, PLASMA; TESTOSTERONE; THYROTROPIN; TRIGLYCERIDES; YOUNG ADULT;

EID: 75749099764     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.10.039     Document Type: Article

References (34)

1. Polson D.W., Adams J., Wadsworth J., and Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1 (1988) 870-872
2. Taylor A.E. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 27 (1998) 877-902
3. Poretsky L., Cataldo N.A., Rosenwaks Z., and Giudice L.C. The insulin-related ovarian regulatory system in health and disease. Endocrinol Rev 20 (1999) 535-582
4. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
5. Hoffstedt J., Wahrenberg H., Thörne A., and Lönnqvist F. The metabolic syndrome is related to beta 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 39 (1996) 838-844
6. Montague C.T., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
7. Quadro L., Hamberger L., Colantuoni V., Gottesman M.E., and Blaner W.S. Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol Aspects Med 24 (2003) 421-430
8. Tsutsumi C., Okuno M., Tannous L., Piantedosi R., Allan M., Goodman D.S., et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267 (1992) 1805-1810
9. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
10. Muoio D.M., and Newgard C.B. Metabolism: A is for adipokine. Nature 436 (2005) 337-338
11. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
12. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
13. Chan T.F., Chen H.S., Chen Y.C., Lee C.H., Chou F.H., Chen I.J., et al. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 14 (2007) 169-174
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
15. O'Meara N.M., Blackman J.D., Ehrmann D.A., Barnes R.B., Jaspan J.B., Rosenfield R.L., et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76 (1993) 1241-1247
16. Weiping L., Qingfeng C., Shikun M., Xiurong L., Hua Q., Xiaoshu B., et al. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30 (2006) 283-287
17. Hahn S., Backhaus M., Broecker-Preuss M., Tan S., Dietz T., Kimmig R., et al. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol 157 (2007) 201-207
18. Tan B.K., Chen J., Lehnert H., Kennedy R., and Randeva H.S. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 92 (2007) 2764-2772
19. Hutchison S.K., Harrison C., Stepto N., Meyer C., and Teede H.J. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care 31 (2008) 1427-1432
20. Möhlig M., Weickert M.O., Ghadamgahi E., Arafat A.M., Spranger J., Pfeiffer A.F., et al. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur J Endocrinol 158 (2008) 517-523
21. Lee D.C., Lee J.W., and Im J.A. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56 (2007) 327-331
22. Erikstrup C., Mortensen O.H., and Pedersen B.K. Retinol-binding protein 4 and insulin resistance. N Engl J Med 355 (2006) 1393-1394
23. Qi Q., Yu Z., Ye X., Zhao F., Huang P., Hu F.B., et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92 (2007) 4827-4834
24. Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., and Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 92 (2007) 2712-2719
25. Takashima N., Tomoike H., and Iwai N. Retinol-binding protein 4 and insulin resistance. N Engl J Med 355 (2006) 1392 author reply 1394-5
26. Choi S.H., Lee Y.J., Park Y.J., Kim K.W., Lee E.J., Lim S., et al. Retinol binding protein-4 elevation is associated with serum TSH level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 93 (2008) 2313-2318
27. Després J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
28. Stefan N., Hennige A.M., Staiger H., Machann J., Schick F., Schleicher E., et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30 (2007) 1173-1178
29. Promintzer M., Krebs M., Todoric J., Luger A., Bischof M.G., Nowotny P., et al. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 92 (2007) 4306-4312
30. Janke J., Engeli S., Boschmann M., Adams F., Böhnke J., Luft F.C., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810
31. Meyer C., Pimenta W., Woerle H.J., Van Haeften T., Szoke E., Mitrakou A., et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29 (2006) 1909-1914
32. Broch M., Vendrell J., Ricart W., Richart C., and Fernández-Real J.M. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 30 (2007) 1802-1806
33. Naylor H.M., and Newcomer M.E. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 38 (1999) 2647-2653
34. Schmutzler C., Gotthardt I., Hofmann P.J., Radovic B., Kovacs G., Stemmler L., et al. Endocrine disruptors and the thyroid gland-a combined in vitro and in vivo analysis of potential new biomarkers. Environ Health Perspect 1 115 Suppl (2007) 77-83